Neuromuscular Blocking Agents for Pediatric Outpatient Procedures
For pediatric patients in the outpatient setting, use rocuronium 0.6 mg/kg as the primary neuromuscular blocking agent for routine intubation, with succinylcholine reserved for rapid sequence induction when not contraindicated. 1
Agent Selection and Dosing
First-Line Agent: Rocuronium
- Rocuronium 0.6 mg/kg provides optimal intubation conditions for routine OPD procedures 2
- Higher doses (>0.9 mg/kg) may be used but are typically reserved for rapid sequence induction 1, 3
- Offers predictable onset, superior hemodynamic stability, and comparable extubation times to lower doses 2
Rapid Sequence Induction Protocol
Succinylcholine remains first-line for RSI in children with age-specific dosing 1, 3:
- < 1 month: 1.8 mg/kg
- 1 month to 1 year: 2.0 mg/kg
- 1-10 years: 1.2 mg/kg
- > 10 years: 1.0 mg/kg
When succinylcholine is contraindicated (myopathies, chronic motor deficits, burns, prolonged immobilization), use rocuronium >0.9 mg/kg 1
Alternative Agents
- Cisatracurium 0.05 mg/kg: Most cost-effective for procedures lasting 1-2 hours requiring continuous blockade 4
- Atracurium, vecuronium: Acceptable alternatives but less commonly used in modern practice
Critical Contraindications
Absolute contraindications to succinylcholine 1:
- Primary muscle damage (myopathies, myotonia) - risk of rhabdomyolysis
- Upregulation of nicotinic receptors (chronic motor deficits, extensive burns >48 hours old, prolonged critical illness) - risk of life-threatening hyperkalemia
- Known neuromuscular disease without proper evaluation
Monitoring Requirements
Quantitative neuromuscular monitoring is essential 1, 5:
- 28% of pediatric patients develop residual neuromuscular blockade 1
- Confirm TOF ratio ≥0.9 before extubation 6
- Monitor at the hand (adductor pollicis) to ensure upper airway muscle recovery 6
Reversal Strategy
Sugammadex is now the preferred reversal agent when rocuronium is used 3:
- Significantly shortens time to TOF 0.9 compared to neostigmine 3
- Dose depends on depth of blockade at time of reversal
- Essential to use quantitative monitoring to determine optimal sugammadex dose and avoid recurarization 6
Special Considerations for OPD Setting
Inhaled Induction
- Muscle relaxants may be beneficial in infants undergoing inhaled induction, improving intubation conditions and reducing respiratory events 1, 3
- In older children, adequate depth of anesthesia and apnea are key; muscle relaxants improve conditions but add allergic risk 1
Common Pitfalls to Avoid
- Underdosing rocuronium: Doses <0.6 mg/kg may provide suboptimal intubation conditions
- Extubating without objective monitoring: Clinical assessment alone misses residual blockade 5
- Using succinylcholine for non-RSI intravenous induction: Not recommended per French regulatory guidance 1
- Inadequate sugammadex dosing: Requires quantitative TOF monitoring to calculate correct dose 6
Practice Pattern Reality Check
Recent survey data reveals concerning heterogeneity: 30% of practitioners "rarely or never" use neuromuscular blocking agents in neonates, and only 27% "always" administer reversal before extubation 5. This practice pattern increases patient safety risk and contradicts guideline recommendations.
Algorithm for Agent Selection
Start here:
Is this RSI?
- Yes → Succinylcholine (age-appropriate dose) unless contraindicated
- Contraindicated → Rocuronium >0.9 mg/kg
Routine intubation?
- Rocuronium 0.6 mg/kg (standard)
- Consider cisatracurium 0.05 mg/kg if cost is primary concern and procedure >1 hour
Neuromuscular disease present?
Before extubation:
- Confirm TOF ratio ≥0.9 with quantitative monitoring
- Administer sugammadex if rocuronium used and TOF <0.9